• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/30

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

30 Cards in this Set

  • Front
  • Back
3 types of lower respiratory tract infections
pneumonia

acute exacerbations of chronic bronchitis

acute bacterial exacerbations of chronic bronchitis
3 routes of lower respiratory tract infections
inhalation

aspiration

hematogenous spread
3 main organisms causing lower respiratory tract infections
S. pneumoniae
H. influenzae
M. catarrhalis
3 atypical organisms causing lower respiratory tract infections
M. pneumoniae
C. pneumoniae
Legionella pneumophia
2 rare organisms causing lower respiratory tract infections
S. aureus
influenza
demographic concerns in lower respiratory tract infections
-age
-comorbidities
-social Hx (travel, close contacts, smoking, EtOH)
-pathogen exposure
clinical presentation of lower respiratory tract infections
-cough
-dyspnea
-sputum production
-pleuritic chest pain
-fever
physical findings of lower respiratory tract infections
tachypnea
tachycardia
inspiratory crackles
diminished breath sounds
inc. WBC, poss left shift
purpose of chest x-ray in lower respiratory tract infections
essential for accurate diagnosis
-rules out other causes of respiratory failure (CHF)
-typical presentation: dense lobar or segmental infiltrates
-rarely negative in the presence of pneumonia
sputum evaluation
gram stain
-rules out rare organisms

culture
-Dx of pathogen
-absence of S. aureus or G- bacilli excludes these organisms
mucopurulent sputum indicates
bacterial infxn
scant/watery sputum indicates
atypical or viral infxn
"rusty" sputum indicates
pneumococcal
staphylococcal
dark red, mucoid sputum indicates
K. pneumoniae
fould-smelling sputum indicates
anaerobic
other diagnostic tests in lower respiratory tract infection
blood cultures
urinary antigen
sputum staining
low-titer cold agglutinin
describe atypical pneumonia
-usual S/Sx not always present
-older patients, comorbidities, travel Hx

-pathogens
--M. or C. pneumoniae
--Legionella pneumophila
describe aspiration pneumonia
-5-10% nosocomial pneumonia
-also occurs in outpatients, but rarely
-risk factors
----altered consciousness due to EtOH or drug OD or seizures
----gingival disease

pathogens
-oral flora
-GI flora
-anaerobes
risk stratification by age
>60-65 years
severe determinants
(hospitalize these people)
neoplasm
hepatic disease
CHF
CVD
renal disease
pathogen determinants
(determine differential diagnosis)
alcoholism
smoking/COPD
poor dentition
who should be hospitalized?
-risk of death or complications
-presence of metastatic disease (pneumonia, not CA)
-presence of comorbidities
-infection by high-risk pathogen
-compliance
-Pneumonia Severity Index (PSI) score
treatment principles for CAP
determine severity of infection
----outpt v. inpatient

consider comorbidities

determine likely pathogen
---cover common typical and atypical pathogens
---monotherapy
CAP Tx - outpatient

no comorbidities
no use of Abx in prev 3 months
macrolide (any)

doxycycline
CAP Tx - outpatient

comorbidities OR
use of Abx in prev 3 months
respiratory FQ (L, M, or G)
OR
macrolide + BL:
-high-dose amoxicillin
-high-dose augmentin
-ceftriaxone
CAP Tx - inpatient

not admitted to ICU
respiratory FQ (L, M, or G)
OR
macrolide + BL:
-high-dose amoxicillin
-high-dose augmentin
-ceftriaxone
CAP Tx - inpatient

admitted to ICU
BL
-ceftriaxone
-Unasyn

AND

azithromycin or resp FQ
RF for HAP
-prior Abx use
-intubation
-advanced age, comorbidities
-H2RA use (aspiration, inc pH allows more GI flora to survive)
-sedation (aspiration)
HAP Tx
No late onset
No risk for MDR pathogens
limited spectrum therapy

ceftriaxone
FQ (L,M)
ertapenem
HAP Tx
late onset OR
risk for MDR pathogens
broad spectrum therapy

1) cefepime/ceftazidime
imipenem, meropenem, doripenem
piperacillin, piperacillin/tazobactam

AND

2) cipro/levo
OR
aminoglycoside